Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Accumulated Expenses (2016 - 2025)

Jaguar Health (JAGX) has disclosed Accumulated Expenses for 11 consecutive years, with $4.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses rose 26.63% to $4.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.2 million, a 26.63% increase, with the full-year FY2024 number at $1.9 million, down 49.68% from a year prior.
  • Accumulated Expenses was $4.2 million for Q3 2025 at Jaguar Health, up from $3.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $10.0 million in Q2 2023 to a low of $1.9 million in Q4 2024.
  • A 5-year average of $5.7 million and a median of $6.1 million in 2021 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 93.68% in 2021, then crashed 66.67% in 2024.
  • Jaguar Health's Accumulated Expenses stood at $7.1 million in 2021, then rose by 14.73% to $8.2 million in 2022, then plummeted by 53.48% to $3.8 million in 2023, then tumbled by 49.68% to $1.9 million in 2024, then skyrocketed by 118.47% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Accumulated Expenses are $4.2 million (Q3 2025), $3.6 million (Q2 2025), and $2.1 million (Q1 2025).